Harmonizing the Collection of Clinical Data on Genetic Testing Requisition Forms to Enhance Variant Interpretation in Hypertrophic Cardiomyopathy (HCM).
Full text not available from this repository.Item Type: | Article |
---|---|
Status: | Published |
Official URL: | https://doi.org/10.1016/j.jmoldx.2021.01.014 |
Journal or Publication Title: | The Journal of Molecular Diagnostics |
Volume: | 23 |
Number: | 5 |
Page Range: | pp. 589-598 |
Date: | May 2021 |
Divisions: | Cardio Genomics Molecular Cardiology |
Depositing User: | General Admin |
Identification Number: | 10.1016/j.jmoldx.2021.01.014 |
ISSN: | 15251578 |
Date Deposited: | 07 Dec 2021 08:45 |
Abstract: | Diagnostic laboratories gather phenotypic data through requisition forms, but there is no consensus as to which data are essential for variant interpretation. The ClinGen Cardiomyopathy Variant Curation Expert Panel defined a phenotypic data set for hypertrophic cardiomyopathy (HCM) variant interpretation, with the goal of standardizing requisition forms. Phenotypic data elements listed on requisition forms from nine leading cardiomyopathy testing laboratories were compiled to assess divergence in data collection. A pilot of 50 HCM cases was implemented to determine the feasibility of harmonizing data collection. Laboratory directors were surveyed to gauge potential for adoption of a minimal data set. Wide divergence was observed in the phenotypic data fields in requisition forms. The 50-case pilot showed that although demographics and assertion of a clinical diagnosis of HCM had 86% to 98% completion, specific phenotypic features, such as degree of left ventricular hypertrophy, ejection fraction, and suspected syndromic disease, were completed only 24% to 44% of the time. Nine data elements were deemed essential for variant classification by the expert panel. Participating laboratories unanimously expressed a willingness to adopt these data elements in their requisition forms. This study demonstrates the value of comparing and sharing best practices through an expert group, such as the ClinGen Program, to enhance variant interpretation, providing a foundation for leveraging cumulative case-level data in public databases and ultimately improving patient care. Copyright © 2021 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved. |
Creators: | Creators Email Morales, Ana UNSPECIFIED Ing, Alexander UNSPECIFIED Antolik, Christian UNSPECIFIED Austin-Tse, Christina UNSPECIFIED Baudhuin, Linnea M. UNSPECIFIED Bronicki, Lucas UNSPECIFIED Cirino, Allison UNSPECIFIED Hawley, Megan H. UNSPECIFIED Fietz, Michael UNSPECIFIED Garcia, John UNSPECIFIED Ho, Carolyn UNSPECIFIED Ingles, Jodie UNSPECIFIED Jarinova, Olga UNSPECIFIED Johnston, Tami UNSPECIFIED Kelly, Melissa A. UNSPECIFIED Kurtz, C. Lisa UNSPECIFIED Lebo, Matt UNSPECIFIED Macaya, Daniela UNSPECIFIED Mahanta, Lisa UNSPECIFIED Maleszewski, Joseph UNSPECIFIED Manrai, Arjun K. UNSPECIFIED Murray, Mitzi UNSPECIFIED Richard, Gabriele UNSPECIFIED Semsarian, Chris UNSPECIFIED Thomson, Kate L. UNSPECIFIED Winder, Tom UNSPECIFIED Ware, James S. UNSPECIFIED Hershberger, Ray E. UNSPECIFIED Funke, Birgit H. UNSPECIFIED Vatta, Matteo UNSPECIFIED |
Last Modified: | 07 Dec 2021 08:45 |
URI: | https://eprints.centenary.org.au/id/eprint/1180 |
Actions (login required)
![]() |
View Item |